[1]
|
Bray, F., Ferlay, J., Soerjomataram, I., et al. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
|
[2]
|
Chen, W., Zheng, R., Baade, P.D., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[3]
|
Tang, W., Xu, P., Wang, H., et al. (2018) MicroRNA-150 Suppresses Triple-Negative Breast Cancer Metastasis through Targeting HMGA2. OncoTargets and Therapy, 11, 2319-2332.
|
[4]
|
Urbanek, M.O., Nawrocka, A.U. and Krzyzosiak, W.J. (2015) Small RNA Detection by in Situ Hybridization Methods. International Journal of Molecular Sciences, 16, 13259-13286. https://doi.org/10.3390/ijms160613259
|
[5]
|
Gualeni, A.V., Volpi, C.C., Carbone, A., et al. (2015) A Novel Semi-Automated in Situ Hybridisation Protocol for Microrna Detection in Paraffin Embedded Tissue Sections. Journal of Clinical Pathology, 68, 661-664.
https://doi.org/10.1136/jclinpath-2015-203005
|
[6]
|
Cassidy, A. and Jones, J. (2014) Developments in in Situ Hybridisation. Methods, 70, 39-45.
https://doi.org/10.1016/j.ymeth.2014.04.006
|
[7]
|
Warford, A. (2016) In Situ Hybridisation: Technologies and Their Application to Understanding Disease. Progress in Histochemistry and Cytochemistry, 50, 37-48. https://doi.org/10.1016/j.proghi.2015.12.001
|
[8]
|
Saraggi, D., Galuppini, F., Fanelli, G.N., et al. (2018) MiR-21 Up-Regulation in Ampullary Adenocarcinoma and Its Pre-Invasive Lesions. Pathology—Research and Practice, 214, 835-839. https://doi.org/10.1016/j.prp.2018.04.018
|
[9]
|
Iida, M., Hazama, S., Tsunedomi, R., et al. (2018) Overexpression of miR-221 and miR-222 in the Cancer Stroma Is Associated with Malignant Potential in Colorectal Cancer. Oncology Reports, 40, 1621-1631.
https://doi.org/10.3892/or.2018.6575
|
[10]
|
He, X., Chen, S.Y., Yang, Z., et al. (2018) miR-4317 Suppresses Non-Small Cell Lung Cancer (NSCLC) by Targeting Fibroblast Growth Factor 9 (FGF9) and Cyclin D2 (CCND2). Journal of Experimental & Clinical Cancer Research, 37, 230. https://doi.org/10.1186/s13046-018-0882-4
|
[11]
|
Cao, M.Q., You, A.B., Zhu, X.D., et al. (2018) miR-182-5p Promotes Hepatocellular Carcinoma Progression by Repressing FOXO3a. Journal of Hematology & Oncology, 11, 12. https://doi.org/10.1186/s13045-018-0555-y
|
[12]
|
Yang, Y., Jiang, Z., Ma, N., et al. (2018) MicroRNA-223 Targeting STIM1 Inhibits the Biological Behavior of Breast Cancer. Cellular Physiology and Biochemistry, 45, 856-866. https://doi.org/10.1159/000487180
|
[13]
|
Johannessen, C., Moi, L., Kiselev, Y., et al. (2017) Expression and Function of the miR-143/145 Cluster in Vitro and in Vivo in Human Breast Cancer. PLoS ONE, 12, e0186658.
|
[14]
|
Mandal, R., Hardin, H., Baus, R., et al. (2017) Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms. Endocrine Pathology, 28, 345-350. https://doi.org/10.1007/s12022-017-9504-5
|
[15]
|
Chu, Y.H., Hardin, H., Schneider, D.F., et al. (2017) MicroRNA-21 and Long Non-Coding RNA MALAT1 Are Overexpressed Markers in Medullary Thyroid Carcinoma. Experimental and Molecular Pathology, 103, 229-236.
|
[16]
|
Zhang, L.X., Jin, W., Zheng, J., et al. (2018) MicroRNA-375 Regulates Proliferation and Apoptosis of Glioma Cancer Cells by Inhibiting CTGF-EGFR Signaling Pathway. Bratislavske Lekarske Listy, 119, 17-21.
|
[17]
|
Long, M., Zhan, M., Xu, S., et al. (2017) miR-92b-3p Acts as a Tumor Suppressor by Targeting Gabra3 in Pancreatic Cancer. Molecular Cancer, 16, 167. https://doi.org/10.1186/s12943-017-0723-7
|
[18]
|
Gurvits, N., Autere, T.A., Repo, H., et al. (2018) Proliferation-Associated miRNAs-494, -205, -21 and -126 Detected by in Situ Hybridization: Expression and Prognostic Potential in Breast Carcinoma Patients. Journal of Cancer Research and Clinical Oncology, 144, 657-666. https://doi.org/10.1007/s00432-018-2586-8
|
[19]
|
Zheng, J.Z., Huang, Y.N., Yao, L., et al. (2018) Elevated miR-301a Expression Indicates a Poor Prognosis for Breast Cancer Patients. Scientific Reports, 8, 2225. https://doi.org/10.1038/s41598-018-20680-y
|
[20]
|
Uozaki, H., Morita, S., Kumagai, A., et al. (2014) Stromal miR-21 Is More Important than miR-21 of Tumour Cells for the Progression of Gastric Cancer. Histopathology, 65, 775-783. https://doi.org/10.1111/his.12491
|
[21]
|
Wang, J., Li, Y., Ding, M., et al. (2017) Molecular Mechanisms and Clinical Applications of miR-22 in Regulating Malignant Progression in Human Cancer (Review). International Journal of Oncology, 50, 345-355.
https://doi.org/10.3892/ijo.2016.3811
|
[22]
|
Xin, M., Qiao, Z., Li, J., et al. (2016) miR-22 Inhibits Tumor Growth and Metastasis by Targeting ATP Citrate Lyase: Evidence in Osteosarcoma, Prostate Cancer, Cervical Cancer and Lung Cancer. Oncotarget, 7, 44252-44265.
https://doi.org/10.18632/oncotarget.10020
|
[23]
|
Liu, H., Huang, X. and Ye, T. (2018) MiR-22 Down-Regulates the Pro-to-Oncogene ATP Citrate Lyase to Inhibit the Growth and Metastasis of Breast Cancer. American Journal of Translational Research, 10, 659-669.
|
[24]
|
Wongjampa, W., Ekalaksananan, T., Chopjitt, P., et al. (2018) Suppression of miR-22, a Tumor Suppressor in Cervical Cancer, by Human Papillomavirus 16 E6 via a p53/miR-22/HDAC6 Pathway. PLoS ONE, 13, e0206644.
|
[25]
|
Feng, X., Luo, Q., Wang, H., et al. (2018) MicroRNA-22 Suppresses Cell Proliferation, Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting NLRP3. Journal of Cellular Physiology, 233, 6705-6713.
https://doi.org/10.1002/jcp.26331
|
[26]
|
Xu, M., Li, J., Wang, X., et al. (2018) MiR-22 Suppresses Epithelial-Mesenchymal Transition in Bladder Cancer by Inhibiting Snail and MAPK1/Slug/Vimentin Feedback Loop. Cell Death & Disease, 9, 209.
https://doi.org/10.1038/s41419-017-0206-1
|
[27]
|
Zuo, Q.F., Cao, L.Y., Yu, T., et al. (2015) MicroRNA-22 Inhibits Tumor Growth and Metastasis in Gastric Cancer by Directly Targeting MMP14 and Snail. Cell Death & Disease, 6, e2000.
|
[28]
|
Jafarzadeh-Samani, Z., Sohrabi, S., Shirmohammadi, K., et al. (2017) Evaluation of miR-22 and miR-20a as Diagnostic Biomarkers for Gastric Cancer. Chinese Clinical Oncology, 6, 16. https://doi.org/10.21037/cco.2017.03.01
|
[29]
|
Wang, J., Zhang, H., Zhou, X., et al. (2018) Five Serum-Based miRNAs Were Identified as Potential Diagnostic Biomarkers in Gastric Cardia Adenocarcinoma. Cancer Biomark, 23, 193-203. https://doi.org/10.3233/CBM-181258
|
[30]
|
Huang, Y., Zhu, J., Li, W., et al. (2018) Serum microRNA Panel Excavated by Machine Learning as a Potential Biomarker for the Detection of Gastric Cancer. Oncology Reports, 39, 1338-1346.
|
[31]
|
Li, S., Liang, X., Ma, L., et al. (2018) MiR-22 Sustains NLRP3 Expression and Attenuates H. Pylori-Induced Gastric Carcinogenesis. Oncogene, 37, 884-896. https://doi.org/10.1038/onc.2017.381
|
[32]
|
Zhang, S., Zhang, D., Yi, C., et al. (2016) MicroRNA-22 Functions as a Tumor Suppressor by Targeting SIRT1 in Renal Cell Carcinoma. Oncology Reports, 35, 559-567. https://doi.org/10.3892/or.2015.4333
|
[33]
|
Bao, B., Li, Y., Ahmad, A., et al. (2012) Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents. Current Drug Targets, 13, 1858-1868. https://doi.org/10.2174/138945012804545515
|
[34]
|
Mohammadian, F., Pilehvar-Soltanahmadi, Y., Alipour, S., et al. (2017) Chrysin Alters microRNAs Expression Levels in Gastric Cancer Cells: Possible Molecular Mechanism. Drug Research, 67, 509-514.
https://doi.org/10.1055/s-0042-119647
|
[35]
|
Mohammadian, F., Abhari, A., Dariushnejad, H., et al. (2016) Effects of Chrysin-PLGA-PEG Nanoparticles on Proliferation and Gene Expression of miRNAs in Gastric Cancer Cell Line. Iranian Journal of Cancer Prevention, 9, e4190.
|
[36]
|
Yi, L. and Su, Q. (2013) Molecular Mechanisms for the Anti-Cancer Effects of Diallyl Disulfide. Food and Chemical Toxicology, 57, 362-370.
|
[37]
|
唐云云, 唐仪, 刘芳, 等. 二烯丙基二硫上调miR-22通过Wnt-1通路抑制人胃癌细胞增殖与迁移侵袭[J]. 中国药理学通报, 2017, 33(8): 1141-1146.
|